Drug Pipeline

Emraclidine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-14 NCT07587008 Study to Assess Adverse Events and How Oral Emraclidine Moves Through the Body of Adult… Phase 1 Not Yet Recruiting
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07145918 A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine… Schizophrenia Recruiting
Phase 1
NCT07219030 A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of… Healthy Volunteer Recruiting
NCT07587008 Study to Assess Adverse Events and How Oral Emraclidine Moves Through the Body of Adult… Healthy Volunteers Not Yet Recruiting
Sponsors Running Emraclidine Trials
AbbVie (3)
Disease Areas
Schizophrenia (1)
Get alerts when Emraclidine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free